<DOC>
	<DOCNO>NCT02820077</DOCNO>
	<brief_summary>This study evaluate efficacy endoscopic hemostatic powder treatment bleed malignant lesion upper GI tract . Half participant receive hemostatic powder half submit standard treatment .</brief_summary>
	<brief_title>Hemostatic Powder Versus Clinical Management Treatment Upper Gastrointestinal Bleeding From Tumor Lesions</brief_title>
	<detailed_description>Gastrointestinal tumor bleed challenge clinical condition high mortality rate . Several endoscopic hemostasis technique test , result disappointing . Re-bleeding mortality rate still high . Hemostatic powder promise therapy tumor bleeding , since apply large surface . Bleeding tumor lesion often occur diffusely surface tumor rather specific vessel .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Any kind malignancy Gastrointestinal bleeding last 48 hour Referred emergency endoscopy 18 year old bleeding non malignant lesion previous endoscopic treatment another method do last 48h</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Endoscopy , Gastrointestinal</keyword>
</DOC>